- IBDEI0HP ; ; 01-FEB-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,7972,2)
- ;;=^5009273
- ;;^UTILITY(U,$J,358.3,7973,0)
- ;;=L71.0^^39^391^273
- ;;^UTILITY(U,$J,358.3,7973,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7973,1,3,0)
- ;;=3^Perioral Dermatitis
- ;;^UTILITY(U,$J,358.3,7973,1,4,0)
- ;;=4^L71.0
- ;;^UTILITY(U,$J,358.3,7973,2)
- ;;=^5009274
- ;;^UTILITY(U,$J,358.3,7974,0)
- ;;=L71.1^^39^391^299
- ;;^UTILITY(U,$J,358.3,7974,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7974,1,3,0)
- ;;=3^Rhinophyma
- ;;^UTILITY(U,$J,358.3,7974,1,4,0)
- ;;=4^L71.1
- ;;^UTILITY(U,$J,358.3,7974,2)
- ;;=^106083
- ;;^UTILITY(U,$J,358.3,7975,0)
- ;;=L71.8^^39^391^300
- ;;^UTILITY(U,$J,358.3,7975,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7975,1,3,0)
- ;;=3^Rosacea NEC
- ;;^UTILITY(U,$J,358.3,7975,1,4,0)
- ;;=4^L71.8
- ;;^UTILITY(U,$J,358.3,7975,2)
- ;;=^5009275
- ;;^UTILITY(U,$J,358.3,7976,0)
- ;;=L71.9^^39^391^301
- ;;^UTILITY(U,$J,358.3,7976,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7976,1,3,0)
- ;;=3^Rosacea,Unspec
- ;;^UTILITY(U,$J,358.3,7976,1,4,0)
- ;;=4^L71.9
- ;;^UTILITY(U,$J,358.3,7976,2)
- ;;=^5009276
- ;;^UTILITY(U,$J,358.3,7977,0)
- ;;=L72.0^^39^391^145
- ;;^UTILITY(U,$J,358.3,7977,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7977,1,3,0)
- ;;=3^Epidermal Cyst
- ;;^UTILITY(U,$J,358.3,7977,1,4,0)
- ;;=4^L72.0
- ;;^UTILITY(U,$J,358.3,7977,2)
- ;;=^5009277
- ;;^UTILITY(U,$J,358.3,7978,0)
- ;;=L72.12^^39^391^325
- ;;^UTILITY(U,$J,358.3,7978,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7978,1,3,0)
- ;;=3^Trichodermal Cyst
- ;;^UTILITY(U,$J,358.3,7978,1,4,0)
- ;;=4^L72.12
- ;;^UTILITY(U,$J,358.3,7978,2)
- ;;=^5009279
- ;;^UTILITY(U,$J,358.3,7979,0)
- ;;=L72.2^^39^391^310
- ;;^UTILITY(U,$J,358.3,7979,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7979,1,3,0)
- ;;=3^Steatocystoma Multiplex
- ;;^UTILITY(U,$J,358.3,7979,1,4,0)
- ;;=4^L72.2
- ;;^UTILITY(U,$J,358.3,7979,2)
- ;;=^5009280
- ;;^UTILITY(U,$J,358.3,7980,0)
- ;;=L72.8^^39^391^154
- ;;^UTILITY(U,$J,358.3,7980,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7980,1,3,0)
- ;;=3^Follicular Cysts of Skin/Subcutaneous Tissue NEC
- ;;^UTILITY(U,$J,358.3,7980,1,4,0)
- ;;=4^L72.8
- ;;^UTILITY(U,$J,358.3,7980,2)
- ;;=^5009282
- ;;^UTILITY(U,$J,358.3,7981,0)
- ;;=L72.9^^39^391^155
- ;;^UTILITY(U,$J,358.3,7981,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7981,1,3,0)
- ;;=3^Follicular Cysts of Skin/Subcutaneous Tissue,Unspec
- ;;^UTILITY(U,$J,358.3,7981,1,4,0)
- ;;=4^L72.9
- ;;^UTILITY(U,$J,358.3,7981,2)
- ;;=^5009283
- ;;^UTILITY(U,$J,358.3,7982,0)
- ;;=L73.0^^39^391^4
- ;;^UTILITY(U,$J,358.3,7982,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7982,1,3,0)
- ;;=3^Acne Keloid
- ;;^UTILITY(U,$J,358.3,7982,1,4,0)
- ;;=4^L73.0
- ;;^UTILITY(U,$J,358.3,7982,2)
- ;;=^2149
- ;;^UTILITY(U,$J,358.3,7983,0)
- ;;=L73.2^^39^391^162
- ;;^UTILITY(U,$J,358.3,7983,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7983,1,3,0)
- ;;=3^Hidradenitis Suppurativa
- ;;^UTILITY(U,$J,358.3,7983,1,4,0)
- ;;=4^L73.2
- ;;^UTILITY(U,$J,358.3,7983,2)
- ;;=^278979
- ;;^UTILITY(U,$J,358.3,7984,0)
- ;;=L73.9^^39^391^156
- ;;^UTILITY(U,$J,358.3,7984,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7984,1,3,0)
- ;;=3^Follicular Disorder,Unspec
- ;;^UTILITY(U,$J,358.3,7984,1,4,0)
- ;;=4^L73.9
- ;;^UTILITY(U,$J,358.3,7984,2)
- ;;=^5009286
- ;;^UTILITY(U,$J,358.3,7985,0)
- ;;=L82.0^^39^391^163
- ;;^UTILITY(U,$J,358.3,7985,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7985,1,3,0)
- ;;=3^Inflamed Seborrheic Keratosis
- ;;^UTILITY(U,$J,358.3,7985,1,4,0)
- ;;=4^L82.0
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0HP 3759 printed Feb 18, 2025@23:15:16 Page 2
- IBDEI0HP ; ; 01-FEB-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,7972,2)
- +2 ;;=^5009273
- +3 ;;^UTILITY(U,$J,358.3,7973,0)
- +4 ;;=L71.0^^39^391^273
- +5 ;;^UTILITY(U,$J,358.3,7973,1,0)
- +6 ;;=^358.31IA^4^2
- +7 ;;^UTILITY(U,$J,358.3,7973,1,3,0)
- +8 ;;=3^Perioral Dermatitis
- +9 ;;^UTILITY(U,$J,358.3,7973,1,4,0)
- +10 ;;=4^L71.0
- +11 ;;^UTILITY(U,$J,358.3,7973,2)
- +12 ;;=^5009274
- +13 ;;^UTILITY(U,$J,358.3,7974,0)
- +14 ;;=L71.1^^39^391^299
- +15 ;;^UTILITY(U,$J,358.3,7974,1,0)
- +16 ;;=^358.31IA^4^2
- +17 ;;^UTILITY(U,$J,358.3,7974,1,3,0)
- +18 ;;=3^Rhinophyma
- +19 ;;^UTILITY(U,$J,358.3,7974,1,4,0)
- +20 ;;=4^L71.1
- +21 ;;^UTILITY(U,$J,358.3,7974,2)
- +22 ;;=^106083
- +23 ;;^UTILITY(U,$J,358.3,7975,0)
- +24 ;;=L71.8^^39^391^300
- +25 ;;^UTILITY(U,$J,358.3,7975,1,0)
- +26 ;;=^358.31IA^4^2
- +27 ;;^UTILITY(U,$J,358.3,7975,1,3,0)
- +28 ;;=3^Rosacea NEC
- +29 ;;^UTILITY(U,$J,358.3,7975,1,4,0)
- +30 ;;=4^L71.8
- +31 ;;^UTILITY(U,$J,358.3,7975,2)
- +32 ;;=^5009275
- +33 ;;^UTILITY(U,$J,358.3,7976,0)
- +34 ;;=L71.9^^39^391^301
- +35 ;;^UTILITY(U,$J,358.3,7976,1,0)
- +36 ;;=^358.31IA^4^2
- +37 ;;^UTILITY(U,$J,358.3,7976,1,3,0)
- +38 ;;=3^Rosacea,Unspec
- +39 ;;^UTILITY(U,$J,358.3,7976,1,4,0)
- +40 ;;=4^L71.9
- +41 ;;^UTILITY(U,$J,358.3,7976,2)
- +42 ;;=^5009276
- +43 ;;^UTILITY(U,$J,358.3,7977,0)
- +44 ;;=L72.0^^39^391^145
- +45 ;;^UTILITY(U,$J,358.3,7977,1,0)
- +46 ;;=^358.31IA^4^2
- +47 ;;^UTILITY(U,$J,358.3,7977,1,3,0)
- +48 ;;=3^Epidermal Cyst
- +49 ;;^UTILITY(U,$J,358.3,7977,1,4,0)
- +50 ;;=4^L72.0
- +51 ;;^UTILITY(U,$J,358.3,7977,2)
- +52 ;;=^5009277
- +53 ;;^UTILITY(U,$J,358.3,7978,0)
- +54 ;;=L72.12^^39^391^325
- +55 ;;^UTILITY(U,$J,358.3,7978,1,0)
- +56 ;;=^358.31IA^4^2
- +57 ;;^UTILITY(U,$J,358.3,7978,1,3,0)
- +58 ;;=3^Trichodermal Cyst
- +59 ;;^UTILITY(U,$J,358.3,7978,1,4,0)
- +60 ;;=4^L72.12
- +61 ;;^UTILITY(U,$J,358.3,7978,2)
- +62 ;;=^5009279
- +63 ;;^UTILITY(U,$J,358.3,7979,0)
- +64 ;;=L72.2^^39^391^310
- +65 ;;^UTILITY(U,$J,358.3,7979,1,0)
- +66 ;;=^358.31IA^4^2
- +67 ;;^UTILITY(U,$J,358.3,7979,1,3,0)
- +68 ;;=3^Steatocystoma Multiplex
- +69 ;;^UTILITY(U,$J,358.3,7979,1,4,0)
- +70 ;;=4^L72.2
- +71 ;;^UTILITY(U,$J,358.3,7979,2)
- +72 ;;=^5009280
- +73 ;;^UTILITY(U,$J,358.3,7980,0)
- +74 ;;=L72.8^^39^391^154
- +75 ;;^UTILITY(U,$J,358.3,7980,1,0)
- +76 ;;=^358.31IA^4^2
- +77 ;;^UTILITY(U,$J,358.3,7980,1,3,0)
- +78 ;;=3^Follicular Cysts of Skin/Subcutaneous Tissue NEC
- +79 ;;^UTILITY(U,$J,358.3,7980,1,4,0)
- +80 ;;=4^L72.8
- +81 ;;^UTILITY(U,$J,358.3,7980,2)
- +82 ;;=^5009282
- +83 ;;^UTILITY(U,$J,358.3,7981,0)
- +84 ;;=L72.9^^39^391^155
- +85 ;;^UTILITY(U,$J,358.3,7981,1,0)
- +86 ;;=^358.31IA^4^2
- +87 ;;^UTILITY(U,$J,358.3,7981,1,3,0)
- +88 ;;=3^Follicular Cysts of Skin/Subcutaneous Tissue,Unspec
- +89 ;;^UTILITY(U,$J,358.3,7981,1,4,0)
- +90 ;;=4^L72.9
- +91 ;;^UTILITY(U,$J,358.3,7981,2)
- +92 ;;=^5009283
- +93 ;;^UTILITY(U,$J,358.3,7982,0)
- +94 ;;=L73.0^^39^391^4
- +95 ;;^UTILITY(U,$J,358.3,7982,1,0)
- +96 ;;=^358.31IA^4^2
- +97 ;;^UTILITY(U,$J,358.3,7982,1,3,0)
- +98 ;;=3^Acne Keloid
- +99 ;;^UTILITY(U,$J,358.3,7982,1,4,0)
- +100 ;;=4^L73.0
- +101 ;;^UTILITY(U,$J,358.3,7982,2)
- +102 ;;=^2149
- +103 ;;^UTILITY(U,$J,358.3,7983,0)
- +104 ;;=L73.2^^39^391^162
- +105 ;;^UTILITY(U,$J,358.3,7983,1,0)
- +106 ;;=^358.31IA^4^2
- +107 ;;^UTILITY(U,$J,358.3,7983,1,3,0)
- +108 ;;=3^Hidradenitis Suppurativa
- +109 ;;^UTILITY(U,$J,358.3,7983,1,4,0)
- +110 ;;=4^L73.2
- +111 ;;^UTILITY(U,$J,358.3,7983,2)
- +112 ;;=^278979
- +113 ;;^UTILITY(U,$J,358.3,7984,0)
- +114 ;;=L73.9^^39^391^156
- +115 ;;^UTILITY(U,$J,358.3,7984,1,0)
- +116 ;;=^358.31IA^4^2
- +117 ;;^UTILITY(U,$J,358.3,7984,1,3,0)
- +118 ;;=3^Follicular Disorder,Unspec
- +119 ;;^UTILITY(U,$J,358.3,7984,1,4,0)
- +120 ;;=4^L73.9
- +121 ;;^UTILITY(U,$J,358.3,7984,2)
- +122 ;;=^5009286
- +123 ;;^UTILITY(U,$J,358.3,7985,0)
- +124 ;;=L82.0^^39^391^163
- +125 ;;^UTILITY(U,$J,358.3,7985,1,0)
- +126 ;;=^358.31IA^4^2
- +127 ;;^UTILITY(U,$J,358.3,7985,1,3,0)
- +128 ;;=3^Inflamed Seborrheic Keratosis
- +129 ;;^UTILITY(U,$J,358.3,7985,1,4,0)
- +130 ;;=4^L82.0